Literature DB >> 30895580

Cytomegalovirus Infection among Infants in Neonatal Intensive Care Units, California, 2005 to 2016.

Chinh Tran1,2, Mihoko V Bennett2,3, Jeffrey B Gould2,3, Henry C Lee2,3, Tatiana M Lanzieri4.   

Abstract

AIM: The main purpose of this article is to assess trends in cytomegalovirus (CMV) infection reported among infants in California neonatal intensive care units (NICUs) during 2005 to 2016. STUDY
DESIGN: The California Perinatal Quality Care Collaborative collects data on all very low birth weight (VLBW, birth weight ≤ 1,500 g) and acutely ill infants > 1,500 g, representing 92% of NICUs in California. We compared clinical characteristics and length of hospital stay among infants with and without reported CMV infection (CMV-positive viral culture or polymerase chain reaction).
RESULTS: During 2005 to 2016, CMV infection was reported in 174 VLBW infants and 145 infants > 1,500 g, or 2.7 (range: 1.5-4.7) and 1.2 (range: 0.8-1.7) per 1,000 infants, respectively (no significant annual trend). Among infants > 1,500 g, 12 (8%) versus 4,928 (4%) of those reported with versus without CMV infection died (p < 0.05). The median hospital stay was significantly longer among infants reported with versus without CMV infection for both VLBW infants (98 vs. 46 days) and infants > 1,500 g (61 vs. 14 days) (p < 0.001).
CONCLUSION: Reports of CMV infection remained stable over a 12-year period. Although we were not able to assess whether infection was congenital or postnatal, CMV infection among infants > 1,500 g was associated with increased mortality. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2019        PMID: 30895580      PMCID: PMC6754307          DOI: 10.1055/s-0039-1683958

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  13 in total

1.  Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates.

Authors:  Marisa Márcia Mussi-Pinhata; Patrícia Cristina Gomes Pinto; Aparecida Yulie Yamamoto; Klara Berencsi; Cleonice Barbosa Sandoval de Souza; Mauro Andrea; Geraldo Duarte; Salim Moyses Jorge
Journal:  J Med Virol       Date:  2003-02       Impact factor: 2.327

2.  A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening.

Authors:  Karen B Fowler; Faye P McCollister; Diane L Sabo; Angela G Shoup; Kris E Owen; Julie L Woodruff; Edith Cox; Lisa S Mohamed; Daniel I Choo; Suresh B Boppana
Journal:  Pediatrics       Date:  2017-01-03       Impact factor: 7.124

3.  Maternal cytomegalovirus excretion and perinatal infection.

Authors:  D W Reynolds; S Stagno; T S Hosty; M Tiller; C A Alford
Journal:  N Engl J Med       Date:  1973-07-05       Impact factor: 91.245

4.  Cytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010.

Authors:  Tatiana M Lanzieri; Stephanie R Bialek; Mihoko V Bennett; Jeffrey B Gould
Journal:  J Perinat Med       Date:  2014-05       Impact factor: 1.901

5.  Cytomegalovirus Shedding in Seropositive Pregnant Women From a High-Seroprevalence Population: The Brazilian Cytomegalovirus Hearing and Maternal Secondary Infection Study.

Authors:  Nayara G Barbosa; Aparecida Y Yamamoto; Geraldo Duarte; Davi C Aragon; Karen B Fowler; Suresh Boppana; William J Britt; Marisa M Mussi-Pinhata
Journal:  Clin Infect Dis       Date:  2018-08-16       Impact factor: 9.079

Review 6.  Predictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment.

Authors:  Julia Gunkel; Tom F W Wolfs; Linda S de Vries; Joppe Nijman
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-02       Impact factor: 5.091

7.  Incidence and impact of CMV infection in very low birth weight infants.

Authors:  Kristen M Turner; Henry C Lee; Suresh B Boppana; Waldemar A Carlo; David A Randolph
Journal:  Pediatrics       Date:  2014-02-02       Impact factor: 7.124

8.  Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.

Authors:  David W Kimberlin; Chin-Yu Lin; Pablo J Sánchez; Gail J Demmler; Wayne Dankner; Mark Shelton; Richard F Jacobs; Wendy Vaudry; Robert F Pass; Jan M Kiell; Seng-jaw Soong; Richard J Whitley
Journal:  J Pediatr       Date:  2003-07       Impact factor: 4.406

9.  Ultrasound abnormalities preceding cerebral palsy in high-risk preterm infants.

Authors:  Linda S De Vries; Inge-Lot C Van Haastert; Karin J Rademaker; Corine Koopman; Floris Groenendaal
Journal:  J Pediatr       Date:  2004-06       Impact factor: 4.406

Review 10.  New advances in the diagnosis of congenital cytomegalovirus infection.

Authors:  Tiziana Lazzarotto; Brunella Guerra; Marcello Lanari; Liliana Gabrielli; Maria Paola Landini
Journal:  J Clin Virol       Date:  2007-12-04       Impact factor: 3.168

View more
  4 in total

1.  Missing diagnoses of congenital cytomegalovirus infection in electronic health records for infants with laboratory-confirmed infection.

Authors:  Alexandra Campione; Tatiana M Lanzieri; Emily Ricotta; Scott D Grosse; Sameer S Kadri; Veronique Nussenblatt; D Rebecca Prevots
Journal:  Curr Med Res Opin       Date:  2021-12-06       Impact factor: 2.705

2.  Association of Adverse Hearing, Growth, and Discharge Age Outcomes With Postnatal Cytomegalovirus Infection in Infants With Very Low Birth Weight.

Authors:  Kristin E D Weimer; Matthew S Kelly; Sallie R Permar; Reese H Clark; Rachel G Greenberg
Journal:  JAMA Pediatr       Date:  2020-02-01       Impact factor: 16.193

3.  Identification of congenital CMV cases in administrative databases and implications for monitoring prevalence, healthcare utilization, and costs.

Authors:  Scott D Grosse; Jessica Leung; Tatiana M Lanzieri
Journal:  Curr Med Res Opin       Date:  2021-03-04       Impact factor: 2.580

Review 4.  Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies.

Authors:  Scott D Grosse; Sheila C Dollard; Ismael R Ortega-Sanchez
Journal:  Semin Perinatol       Date:  2021-01-23       Impact factor: 3.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.